Tilray Brands (TLRY) Hits New All-Time High as Trump Promotes Cannabis, CBD for Medical Use

Core Viewpoint - Tilray Brands Inc. (NASDAQ:TLRY) experienced a significant surge in stock price, reaching an all-time high following President Donald Trump's promotion of cannabis and cannabidiol (CBD) for medical use in the US [1][2][3] Group 1: Stock Performance - In intra-day trading, Tilray's stock hit a peak price of $1.86 before closing at $1.85, reflecting a 60.87% increase [2] - The announcement regarding the potential benefits of CBD oil, including a projected reduction in US healthcare costs by $64 billion, contributed to the rise in Tilray's share price [3] Group 2: Market Impact - The promotion of cannabis and CBD by Trump positively influenced the stock prices of various cannabis product manufacturers, including Tilray Brands, Canopy Growth, Cronos Group, and Aurora Cannabis [3]